# Caxton Advantage Life Sciences Fund: portfolio, investments and team > Caxton Advantage Life Sciences Fund is a growth equity based in United States. 12 investments on record, latest Aug 2014. Source: https://millionrounds.com/fund/caxton-advantage-life-sciences-fund (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Caxton Advantage Life Sciences Fund No cheque observed since Aug 2014, after 12 earlier cheques, and the website is dead. Dormant Growth equity Series C Growth Series D Cheques on record **0%** of best year **0** **cheques in 12 months**, 12 on record Since the last cheque **4466** days **00** hrs **00** min **00** sec Median round **$31M** Rounds led **0 of 12** Exits **3 from the portfolio** Mostly in **United States, 75%** Pitch Caxton Advantage Life Sciences Fund ## Caxton Advantage Life Sciences Fund highlights - 01 12 rounds on record - 02 Mostly Series C and Growth: 50% of its rounds - 03 3 exits from the portfolio ## What they do - **Type:** Growth equity (from a list, unverified) - **Cheque size:** Not stated - **Based in:** United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **12 appearances** - **2014** 1 round - **Aug** **[Mevion Medical Systems](https://millionrounds.com/company/mevion-medical-systems)** Growth · US **$200M** With 5 others - **2013** 1 round - **Jun** **[Mevion Medical Systems](https://millionrounds.com/company/mevion-medical-systems)** Growth · US · finsmes.com **$55M** With 3 others - **2012** 1 round - **Dec** **[Regado Biosciences](https://millionrounds.com/company/regado-biosciences)** Series E · US · regadobio.investorroom.com **$51M** With 8 others - **2010** 2 rounds - **Aug** **[Gemin X Pharmaceuticals](https://millionrounds.com/company/gemin-x-pharmaceuticals)** Series E · CA · onbiovc.com **$8.0M** With 1 other - **Apr** **[Gemin X Pharmaceuticals](https://millionrounds.com/company/gemin-x-pharmaceuticals)** Series D · CA · fiercebiotech.com **$16M** With 1 other - **2009** 2 rounds - **Dec** **[Regado Biosciences](https://millionrounds.com/company/regado-biosciences)** Series D · US · regadobio.com **$40M** With 5 others - **Apr** **[Sunesis Pharmaceuticals](https://millionrounds.com/company/sunesis-pharmaceuticals)** Venture · US · pehub.com **$44M** With 8 others - **2008** 2 rounds - **Aug** **[Anthera Pharmaceuticals](https://millionrounds.com/company/anthera-pharmaceuticals)** Venture · US **$19M** With 5 others - **Jul** **[Gemin X Pharmaceuticals](https://millionrounds.com/company/gemin-x-pharmaceuticals)** Series C · CA · siliconindia.com **$38M** With 12 others - **2007** 3 rounds - **Dec** **[Corthera](https://millionrounds.com/company/corthera)** Series C · US · basmedical.com **$23M** With 2 others - **Oct** **[Mevion Medical Systems](https://millionrounds.com/company/mevion-medical-systems)** Series C · US **$6.9M** With 2 others - **Mar** **[Regado Biosciences](https://millionrounds.com/company/regado-biosciences)** Series C · US · regadobio.investorroom.com **$23M** With 3 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **1** person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## Exits from the portfolio Companies it backed that were later bought or listed **3 in all** **[Gemin X Pharmaceuticals](https://millionrounds.com/company/gemin-x-pharmaceuticals)** Bought by [Cephalon](https://millionrounds.com/fund/cephalon) **$525M** Mar 2011 **[Anthera Pharmaceuticals](https://millionrounds.com/company/anthera-pharmaceuticals)** Listed **Undisclosed** Mar 2010 **[Corthera](https://millionrounds.com/company/corthera)** Bought by [Novartis](https://millionrounds.com/fund/novartis) **$620M** Dec 2009 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Series C Growth Series D Median round joined **$31M** the round, not its cheque Led 0 of 12 rounds **0%** - **Sole investor:** Never alone - **Last cheque:** Aug 2014 - **Exits:** 3 from the portfolio Rounds by stage said on their site - Series C *4* - Growth *2* - Series D *2* - Series E *2* - Venture *2* Cheques by year Led Joined 2007 2014 Often in the room with - [Domain Associates](https://millionrounds.com/fund/domain-associates) 4 - [Venrock](https://millionrounds.com/fund/venrock) 4 - [CHL Medical Partners](https://millionrounds.com/fund/chl-medical-partners) 3 - [ProQuest Investments](https://millionrounds.com/fund/proquest-investments) 3 - [Quaker Partners](https://millionrounds.com/fund/quaker-partners) 3 - [Sanderling Ventures](https://millionrounds.com/fund/sanderling-ventures) 3 **Pitching Caxton Advantage Life Sciences Fund?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Caxton Advantage Life Sciences Fund. A count of rooms they were both in, not a relationship either has claimed. [**Domain Associates** VC firm **4** rounds together](https://millionrounds.com/fund/domain-associates)[**Venrock** VC firm **4** rounds together](https://millionrounds.com/fund/venrock)[**CHL Medical Partners** VC firm **3** rounds together](https://millionrounds.com/fund/chl-medical-partners)[**ProQuest Investments** VC firm **3** rounds together](https://millionrounds.com/fund/proquest-investments)[**Quaker Partners** VC firm **3** rounds together](https://millionrounds.com/fund/quaker-partners)[**Sanderling Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/sanderling-ventures)[**The Aurora Funds** VC firm **3** rounds together](https://millionrounds.com/fund/the-aurora-funds)[**Aurora Funds** Growth equity **2** rounds together](https://millionrounds.com/fund/aurora-funds)[**Edmond de Rothschild Venture Capital** Growth equity **2** rounds together](https://millionrounds.com/fund/edmond-de-rothschild-venture-capital)[**VantagePoint Capital Partners** VC firm **2** rounds together](https://millionrounds.com/fund/vantagepoint-capital-partners) ## Quick answers about Caxton Advantage Life Sciences Fund ### What does Caxton Advantage Life Sciences Fund invest in? Caxton Advantage Life Sciences Fund invests most often at Series C and Growth (50% of the rounds on record). ### How active is Caxton Advantage Life Sciences Fund? 12 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2014. ### How big are Caxton Advantage Life Sciences Fund's cheques? The median round it joins is $31M. ### Does Caxton Advantage Life Sciences Fund lead rounds? Rarely, if at all: none of its 12 investments on record names it as the lead. ### Where does Caxton Advantage Life Sciences Fund invest? Most of the companies it backs are in the United States (75%) and Canada (25%). ### Is Caxton Advantage Life Sciences Fund investing now? It looks quiet: no investment on record since Aug 2014. ### Who does Caxton Advantage Life Sciences Fund invest alongside? Most often Domain Associates (4 rounds together), Venrock (4 rounds together) and CHL Medical Partners (3 rounds together). ### What kind of investor is Caxton Advantage Life Sciences Fund? Caxton Advantage Life Sciences Fund is a growth equity firm based in United States. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=caxton-advantage-life-sciences-fund) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=caxton-advantage-life-sciences-fund)